Blog

Nuance’s Dragon Drive Powers New Conversational In-Car Infotainment

 Nuance Communications, Inc. (NASDAQ: NUAN) today announced that its Dragon Drive connected car voice technologies power the in-car infotainment systems for BMW Group vehicle models in 2015 and 2016. The BMW Group 7Series was the first to hit the market this year featuring a conversational user interface built with Nuance’s hybrid embedded-cloud voice recognition, natural language understanding (NLU), barge-in and text-to-speech solutions – that together create intuitive access to in-car functions and connected services while minimizing distraction.

The BMW Group is the first to ship Nuance’s latest automotive voice recognition and NLU technology built on Deep Neural Networks for faster and more accurate results delivering a better user experience. The fully integrated, automotive-grade solution enables quick and easy access to apps and services, such as navigation, music, message dictation, the calendar, weather, social media and more through a conversational voice interface – all accessible by voice from the top menu, unleashing a level of user experience unmatched by aftermarket third-party mobile phone solutions. Drivers are able to say commands in one phrase, such as “Send a text message to Joe, I am stuck in traffic and will be 15 minutes late,” or “Get me directions to Armando’s Pizza in Cambridge.” Drivers can also speak over or interrupt the system to complete tasks faster.

 

Read More

Codeship Announces Integration with Amazon EC2 Container Registry

Codeship, a hosted continuous integration service for testing and deploying code, today announced integration with Amazon EC2 Container Registry (Amazon ECR), a fully-managed service for storing, managing, and deploying Docker container images. This latest integration extends Codeship’s ability to support AWS customers that use Docker.

“This integration with Amazon ECR is central to our continuous delivery capability with Docker,” said Moritz Plassnig, CEO of Codeship. “Our continuous integration platform can scale with the AWS infrastructure and is a great fit for large companies that are looking for higher quality and more secure tools. It helps us make life easier for users who are part of the AWS ecosystem.”

 

Read More

Blueprint Medicines Added to NASDAQ Biotechnology Index

Blueprint Medicines(NASDAQ: BPMC), a leader in discovering and developing highly selective kinase medicines for patients with genomically defined diseases, today announced that it has been added to the NASDAQ Biotechnology Index® (NASDAQ: NBI). The annual re-constitution of the NASDAQ Biotechnology Index will become effective upon market open on Monday, December 21, 2015.

The NASDAQ Biotechnology Index is designed to track the performance of a set of securities listed on The NASDAQ Stock Market ® (NASDAQ®) that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark (ICB). The NASDAQ Biotechnology Index is calculated under a modified capitalization-weighted methodology and ranked on an annual basis. All securities in the NASDAQ Biotechnology Index are listed on the NASDAQ Global Market or the NASDAQ Global Select Market and meet certain eligibility requirements.

 

Read More

Unum Therapeutics Announces Recombinant DNA Advisory Committee’s (RAC) Unanimous Approval of Phase 1 Study Protocol to Evaluate ACTR Cell Therapy in Non-Hodgkin Lymphoma

Unum Therapeutics, a company developing a universal cellular immunotherapy to treat multiple cancers, announced today that it has received unanimous approval by the National Institute of Health’s (NIH) Recombinant DNA Advisory Committee (RAC) for its first U.S.-based clinical trial. The Phase 1 trial will evaluate Unum’s Antibody-Coupled T-cell Receptor (ACTR) platform in Non-Hodgkin Lymphoma (NHL) patients who have failed to respond or relapsed following treatment with chemotherapy plus rituximab. Under the protocol, Unum will co-administer ACTR T-cells and rituximab to target and attack CD20-positive tumor cells.

 

Read More

Ping Identity Accelerates Disruption of Legacy Web Access Management Solutions as More Enterprises Embrace Cloud and Mobility

Ping Identity®, the leader of Identity Defined Security, today announced growing momentum and customer adoption of PingAccess, a comprehensive solution to transition from legacy web access management (WAM) products to connect users, applications and partners across modern web, mobile and API architectures.

Ping Identity is at the Gartner Identity and Access Management Summit this week in Las Vegas. Patrick Harding, chief technology officer at Ping Identity, will present a session with Ranjan Jain, security architect at Cisco, titled “Securing and Streamlining Your Partner Ecosystem” on Wednesday, December 9 at 10:30 a.m. PT. Attendees can visit Ping Identity’s booth #212 for a product demo and to learn more about the company’s leadership inIdentity Defined Security, including its strategy to provide modern access management in web, mobile and API architectures.

 

Read More

Dimension Therapeutics Reports Recent Corporate Progress and Third Quarter 2015 Financial Results

Dimension Therapeutics, Inc.(NASDAQ:DMTX), a leading gene therapy company advancing novel, liver-directed treatments for diverse rare diseases, today reported financial results for the third quarter ended September 30, 2015, and provided an update on the company’s recent corporate progress.

“With the proceeds from our IPO, we are well-capitalized to maintain the momentum of our gene therapy product portfolio, particularly DTX101, our lead product candidate for hemophilia B which we expect will enter phase 1/2 clinical development by the end of this year,” said Annalisa Jenkins, MBBS, MRCP, Chief Executive Officer of Dimension. “Additionally, we are in a strong position to rapidly advance multiple development programs addressing significant unmet medical needs for patients living with rare genetic disorders associated with the liver.”

 

Read More

Codeship Raises Another $1.5 Million

Codeship, a Boston startup that helps software companies quickly update their applications, has raised $1.5 million in a new funding round, the company said Thursday.

The investment came mostly from earlier investors Sigma Prime Ventures, Boston Seed Capital, and F-Prime Capital. The company has now raised a total of $4.4 million.

“Based on our tremendous growth, we are encouraged to continue delivering the best solutions to our customers,” said Moritz Plassnig, Codeship’s chief executive. “This new funding helps us to invest more in improving their technology. By refining our products and beefing up operations, Codeship can scale more quickly and better support large companies with their DevOps needs.”

 

Read More

Acacia Pharma: Dr Patrick Vink to Succeed Ian Kent as Non-Executive Chairman

Acacia Pharma Group plc (“Acacia Pharma”), the supportive care company developing products for US and international markets, today announces that Ian Kent will retire as non-executive Chairman on 31st December 2015 and will be succeeded by Dr Patrick Vink.

Patrick Vink most recently served as chief operating officer of Cubist Pharmaceuticals, joining there from senior roles at Mylan Inc., including having global responsibility for the group’s hospital business. Previously Patrick held several leadership positions with Novartis Sandoz, Sanofi and Biogen, principally in global commercial roles. He is also a non-executive director of Inhibikase Inc. and Micreos BV.

 

Read More

Tetraphase Pharmaceuticals to Present at Oppenheimer 26th Annual Healthcare Conference

Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced thatGuy Macdonald, Tetraphase’s President and Chief Executive Officer, will present at the Oppenheimer 26th Annual Healthcare Conference onTuesday, December 8th at 4:30 p.m. Eastern Time at the Westin Grand Central Hotel in New York City.

A live audio webcast of the Oppenheimer presentation will be available on the company’s website at http://ir.tphase.com/events.cfm.  An archived presentation will be available for 90 days.

 

Read More

Tradier Reaches Milestone of 100 Financial Services Firms Integrating Directly with its Brokerage Platform

Tradier, Inc., the innovative cloud-based financial services API firm, today announced that over 100 financial technology companies are now adopting its Tradier API to provide individual investors, traders and advisors with convenient and easy access to brokerage services. As the fastest-growing brokerage technology firm, Tradier is at the forefront of the brokerage-as-a-service evolution, democratizing access to brokerage capabilities for third party financial technology providers and allowing for greater access to capital markets for retail investors. The Tradier API is leading the fast-growing era of investor choice by eliminating the need for financial platforms and developers to invest in costly and infrastructure and massive regulatory hurdles to gain access to brokerage services.

 

Read More